Announcements Trials
Browse Landscape

Phase

Phase 3 9Phase NA 8Phase 4 7Phase 2 6Phase EARLY_PHASE1 3Phase 1/2 1Phase 1 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3Gynecologic 1Gastrointestinal 1

Conditions

Breast Neoplasms 3

Interventions

Letrozole 9Fluorodeoxyglucose F18 7pembrolizumab 6Magnetic Resonance Spectroscopy 6atezolizumab 5Blood Specimen Collection 5Trastuzumab 4Oncolytic Virotherapy 4Biopsy 4Bevacizumab 4palbociclib 3durvalumab 3Vitamin D 3Taxes 3Saline Solution 3Radiotherapy 3Metformin 3Fish Oils 3Docosahexaenoic Acids 3Denosumab 3Carboplatin 3Albumin-Bound Paclitaxel 3pertuzumab 2olaparib 2bazedoxifene 2Vinorelbine 2Tamoxifen 2Sentinel Lymph Node Biopsy 2Positron-Emission Tomography 2Positron Emission Tomography Computed Tomography 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Saline Solution × Breast × Clear all
NCT04019834 2022-08-03

RELIEF

University of Alabama at Birmingham

Phase EARLY_PHASE1 Completed
21 enrolled
Breast

Breast Neoplasms

NCT02806817 2019-07-23

ME-344 in Early HER2-negative Breast Cancer With Antiangiogenic-induced Mitochondrial Metabolism

Centro Nacional de Investigaciones Oncologicas CARLOS III

Phase EARLY_PHASE1 Completed
40 enrolled
Breast

Breast Neoplasms

NCT02719795 2017-02-17

PNBCP

First Affiliated Hospital Xi'an Jiaotong University

Phase EARLY_PHASE1 Unknown
140 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡